Searched for
ARICEPT
Lupin launches generic Aricept tablets in US marketLupin's product is a generic version of Eisai Inc's Aricept tablets which is indicated for the treatment of dementia of the Alzheimer's typ...- Lupin gets FDA nod for generic Aricept tabletsLupin said it has received final approval from the US drug regulator to market generic Aricept tablets used for treatment of dementia.
- Sensex turns choppy after positive start; top eight stocks in focusThe Sensex turned choppy after opening on a positive note on Thursday, led by losses in banks, realty, FMCG and capital goods stocks.
- Eight stocks in focus in Thursday morning tradeIndian markets are likely to trade in a range. Here is a list of eight stocks which are likely to be in focus in trade today.
- Ranbaxy gets Health Canada nod for generic anti-dementia drugDrug maker Ranbaxy Laboratories today announced receipt of approval from Health Canada to sell generic version of Pfizer's Aricept.
- Japan's Eisai to launch breast cancer drug in IndiaJapan's Eisai Pharma is slated to launch in India its novel anti-cancer drug Eribulin, sold under the brand name of Halaven.
- Dr Reddy's launches Alzheimer's disease drug in US marketDr Reddy's Laboratories today said it has launched generic Donepezil Hydrochloride tablets, used to treat Alzheimer's disease, in the US ma...
- 10% upside to Ranbaxy if approval comes from USFDA: IIFLIn an interview with ET Now, Bino Pathiparampil, Analyst, Pharma, Institutional Equities, IIFL, talks about Ranbaxy. Excerpts:
- Dr Reddy’s Labs launches three generic products in USADr Reddy’s Laboratories announced today that it launched three generic drugs in the US market.
- Wockhardt receives USFDA nod for generic Aricept tabletsWockhardt Ltd today said it has received tentative approval from the US health regulator to sell a generic copy of Aricept tablets.
- Ranbaxy shares dive 7% as Mylan sues USFDA over Lipitor approvalFor investors of Ranbaxy Labs, it has been a rough ride. The drugmaker has encountered a series of setbacks and its stock has been pummelle...
- Ranbaxy: Poor business outside India hurts numbersRanbaxy Labs, the country's largest pharma company, posted a dismal performance in its fourth quarter.
- TCS, L&T, Ranbaxy top brokers' favourites listTCS, L&T and Ranbaxy figure on top of the list of stocks that broking firms are asking investors to buy even as the markets slide.
- Ranbaxy: Rich product line may attract investor interestA successful approval for Aricept should improve investor confidence in Ranbaxy’s ability to convert its FTF applications.
- Ranbaxy gets US nod for Alzheimer's drugRanbaxy on Tuesday said it has received final approval from the US health regulator to manufacture and market generic Donepezil Hydrochlori...
- Sun Pharma receives USFDA nod for generic Alzheimer's drugSun Pharmaceutical Industries said it has received a tentative approval from US health regulator to market generic donepezil hydrochloride ...
- Ranbaxy drug gets US nodRanbaxy Laboratories got the exclusive rights to market a generic version of Japanese firm Eisai's blockbuster Alzheimer's drug in the US f...
- Ranbaxy gets US FDA approval to sell Alzheimer's disease drugRanbaxy Laboratories on Tuesday said it has received approval from the US health regulator to sell generic Alzheimer's disease drug donepez...
- Ranbaxy gets USFDA nod to mkt generic copy of AriceptRanbaxy Laboratories has received tentative approval from the US Food and Drug Administration (USFDA) to manufacture and market donepezil h...
- Tokyo's Eisai to invest Rs 500 cr in Vizag SEZTokyo-based pharma major Eisai has zoomed on India to set up a new Rs 500 crore manufacturing and R&D centre.
Load More
